Skip to main content
Log in

Synthesis and characterization of collagen/hydroxyapatite: magnetite composite material for bone cancer treatment

  • Published:
Journal of Materials Science: Materials in Medicine Aims and scope Submit manuscript

Abstract

Our purpose was obtaining and characterizing a complex composite system with multifunctional role: bone graft material and hyperthermia generator necessary for bone cancer therapy. The designed system was a magnetite enriched collagen/hydroxyapatite composite material, obtained by a co-precipitation method. Due to the applied electromagnetic field the magnetite will induce hyperthermia and cause tumoral cell apoptosis. The complex bone graft system was characterised by XRD, FTIR and SEM, while the hyperthermia was quantify by measuring the temperature increase due to the applied alternative electromagnetical field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Brahler M, Georgieva R, Buske N, Muller A, Muller S, Pinkernelle J, et al. Magnetite-loaded carrier erythrocytes as contrast agents for magnetic resonance imaging. Nano Lett. 2006;6(11):2505–9.

    Article  CAS  PubMed  ADS  Google Scholar 

  2. Lin CY, Ho KC. Synthesis of superparamagnetic magnetite nanoparticles for thermoresponsive drug delivery. Nanotechnology. 2007;2:405–8.

    CAS  Google Scholar 

  3. Yang J, Lee H, Hyung W, Park S-B, Haam S. Magnetic PECA nanoparticles as drug carriers for targeted delivery: synthesis and release characteristics. J Microencapsul. 2006;23(2):203–12.

    Article  CAS  PubMed  Google Scholar 

  4. Matsuoka F, Shinkai M, Honda H, Kubo T, Sugita T, Kobayashi T. Hyperthermia using magnetite cationic liposomes for hamster osteosarcoma. Biomagn Res Technol. 2004;2(1):3.

    Article  PubMed  Google Scholar 

  5. Orentas R, Hodge JW, Johnson BD, editors. Cancer vaccines and tumor immunity. New York: Wiley; 2008.

    Google Scholar 

  6. Li BQ, Jia DC, Zhou Y, Hu QL, Cai W. Magnetic hydroxyapatite/chitosan nanocomposites via in situ hybridization strategy. Bioceramics. 2007;330–332(Pts 1–2):357–60.

    Google Scholar 

  7. Wu J, Hu QL, Chen FP, Li BQ, Shen JC. Study of the mechanical property of magnetite/hydroxyapatite/chitosan nano-composite. Bioceramics. 2007;330–332(Pts 1–2):435–8.

    Google Scholar 

  8. Cui W, Hu QL, Wu J, Li BQ, Shen JC. Preparation and characterization of magnetite/hydroxyapatite/chitosan nanocomposite by in situ compositing method. J Appl Polym Sci. 2008;109(4):2081–8.

    Article  CAS  Google Scholar 

  9. Murakami S, Hosono T, Jeyadevan B, Kamitakahara M, Ioku K. Hydrothermal synthesis of magnetite/hydroxyapatite composite material for hyperthermia therapy for bone cancer. J Ceram Soc Jpn. 2008;116(1357):950–4.

    Article  CAS  Google Scholar 

  10. Ruel-Gariepy E, Shive M, Bichara A, Berrada M, Le Garrec D, Chenite A, et al. A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur J Pharm Biopharm. 2004;57(1):53–63.

    Article  CAS  PubMed  Google Scholar 

  11. Yan XL, Gemeinhart RA. Cisplatin delivery from poly(acrylic acid-co-methyl methacrylate) microparticles. J Control Release. 2005;106(1–2):198–208.

    Article  CAS  PubMed  Google Scholar 

  12. Ta HT, Dass CR, Dunstan DE. Injectable chitosan hydrogels for localised cancer therapy. J Control Release. 2008;126(3):205–16.

    Article  CAS  PubMed  Google Scholar 

  13. Reddy LH, Sharma RK, Chuttani K, Mishra AK, Murthy RSR. Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton’s lymphoma tumor bearing mice. J Control Release. 2005;105(3):185–98.

    Article  CAS  Google Scholar 

  14. Miyazaki T, Yomota C, Okada S. Development and release characterization of hyaluronan-doxycycline gels based on metal coordination. J Control Release. 2001;76(3):337–47.

    Article  CAS  PubMed  Google Scholar 

  15. Konishi M, Tabata Y, Kariya M, Hosseinkhani H, Suzuki A, Fukuhara K, et al. In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel. J Control Release. 2005;103(1):7–19.

    Article  CAS  PubMed  Google Scholar 

  16. Kim JH, Kim YS, Park K, Lee S, Nam HY, Min KH, et al. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release. 2008;127(1):41–9.

    Article  CAS  PubMed  Google Scholar 

  17. Harashima H, Iida S, Urakami Y, Tsuchihashi M, Kiwada H. Optimization of anti-tumor effect of liposomally encapsulated doxorubicin based on simulations by pharmacokinetic/pharmacodynamic modeling. J Control Release. 1999;61(1–2):93–106.

    Article  CAS  PubMed  Google Scholar 

  18. Cafaggi S, Russo E, Stefani R, Leardi R, Caviglioli G, Parodi B, et al. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex. J Control Release. 2007;121(1–2):110–23.

    Article  CAS  PubMed  Google Scholar 

  19. Wang JP, Takayama K, Nagai T, Maitani Y. Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol. Int J Pharm. 2003;251(1–2):13–21.

    CAS  Google Scholar 

  20. Netz DJA, Sepulveda P, Pandolfelli VC, Spadaro ACC, Alencastre JB, Bentley MVLB, et al. Potential use of gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system. Int J Pharm. 2001;213(1–2):117–25.

    Article  CAS  PubMed  Google Scholar 

  21. Xu R, Ma J, Sun XC, Chen ZP, Jiang XL, Guo ZR, et al. Ag nanoparticles sensitize IR-induced killing of cancer cells. Cell Res. 2009;19(8):1031–4.

    Article  CAS  PubMed  Google Scholar 

  22. Melnikov OV, Gorbenko OY, Markelova MN, Kaul AR, Atsarkin VA, Demidov VV, et al. Ag-doped manganite nanoparticles: new materials for temperature-controlled medical hyperthermia. J Biomed Mater Res A. 2009;91A(4):1048–55.

    Article  CAS  Google Scholar 

  23. Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, McLaughlin RE, et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 2004;11(3):169–83.

    Article  CAS  PubMed  Google Scholar 

  24. Ficai A, Andronescu E, Ghitulica C, Voicu G, Trandafir V, Manzu D, et al. Collagen/hydroxyapatite interactions in composite biomaterials. Mater Plast. 2009;46(1):11–5.

    CAS  Google Scholar 

  25. Li Y, Asadi A, Monroe MR, Douglas EP. pH effects on collagen fibrillogenesis in vitro: electrostatic interactions and phosphate binding. Mater Sci Eng C. 2009;29(5):1643–9.

    Article  CAS  Google Scholar 

  26. Ficai A, Andronescu E, Voicu G, Ghitulica C, Ficai D. The influence of collagen support and ionic species on the morphology of collagen/hydroxyapatite composite materials. Mater Charact. 2010;61:402–7. doi:10.1016/j.matchar.2010.01.003.

    Article  CAS  Google Scholar 

  27. Ficai A, Andronescu E, Trandafir V, Ghitulica C, Voicu G. Collagen/hydroxyapatite composite obtained by electric field orientation. Mater Lett. 2010;64(4):541–4.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are gratefully thanks to Chem. Madalina ALBU to provide us the collagen gel. This work was partially supported by Romanian National Authority for Scientific Research through project 72_198/2008.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anton Ficai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andronescu, E., Ficai, M., Voicu, G. et al. Synthesis and characterization of collagen/hydroxyapatite: magnetite composite material for bone cancer treatment. J Mater Sci: Mater Med 21, 2237–2242 (2010). https://doi.org/10.1007/s10856-010-4076-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10856-010-4076-7

Keywords

Navigation